LS Investment Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

LS Investment Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,076	Closed	-$461K	–	770
2021 Q1	$461K	Sell	6,076 -389	-6%	-$29.3K	0.03%	411
2020 Q4	$440K	Buy	6,465 +1,388	+27%	+$86.5K	0.02%	467
2020 Q3	$270K	Sell	5,077 -141	-3%	-$8.4K	0.02%	602
2020 Q2	$304K	Buy	5,218 +179	+4%	+$9.62K	0.02%	558
2020 Q1	$199K	Hold	5,039	–	–	0.01%	632
2019 Q4	$300K	Buy	5,039 +1,627	+48%	+$87.5K	0.02%	657
2019 Q3	$182K	Buy	3,412 +138	+4%	+$7.08K	0.01%	810
2019 Q2	$167K	Sell	3,274 -170	-5%	-$7.92K	0.01%	865
2019 Q1	$178K	Sell	3,444 -148	-4%	-$7.17K	0.01%	843
2018 Q4	$141K	Sell	3,592 -46	-1%	-$2.14K	0.01%	898
2018 Q3	$188K	Buy	3,638 +215	+6%	+$10.5K	0.01%	880
2018 Q2	$161K	Buy	3,423 +176	+5%	+$7.29K	0.01%	973
2018 Q1	$115K	Sell	3,247 -624	-16%	-$24.4K	0.01%	1082
2017 Q4	$169K	Sell	3,871 -3,013	-44%	-$141K	0.01%	982
2017 Q3	$360K	Buy	6,884 +872	+15%	+$48.6K	0.02%	675
2017 Q2	$352K	Buy	+6,012	New	+$312K	0.02%	667

Other funds holding SYNH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

LS Investment Advisors's SYNH Position: Q2 2021 in Review

LS Investment Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 6,076 shares — an estimated $461K sold.

LS Investment Advisors first reported a position in SYNH in Q2 2017 and held it in 16 quarters. The position peaked at $461K in Q1 2021. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

LS Investment Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
LS Investment Advisors sold 6,076 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $461K.
LS Investment Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 16 quarters.
LS Investment Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $461K in Q1 2021.
342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.